The COVID-19 pandemic and its hallmark features of taste and smell loss highlight the need for smell and taste testing as a routine part of medical care.

Program host: Caroline Huart and Ilja Croijmans

Technical host: Danielle R. Reed

Organizers: Caroline Huart and Ilja Croijmans

Leadership team liaison: Marga Veldhuizen

Webinar timestamps:

00:00 Welcome from the Webinar organizers

00:00 Thomas Hummel, M.D. Smell and Taste Clinic, Department of Otorhinolaryngology, Technische Universität Dresden, Dresden, Germany “Current perspectives on the treatment of COVID-19 associated taste and smell loss”

00:15 Jonathan Overdevest, M.D., Ph.D. Columbia University, USA “Current clinical strategies for COVID-19 taste and smell loss”

00:30 Carol Yan, M.D. University of California San Diego, Division of Otolaryngology Dept of Surgery “The use of platelet-rich plasma in treatment of olfactory dysfunction”

00:45 Bradley Goldstein, M.D., Ph.D. Duke University, USA “Therapeutic potential and olfactory basal stem cells”

Program host: Tristram Wyatt

Technical host: Danielle R. Reed

Organizers: Caroline Huart and Ilja Croijmans

Leadership team liaison: Marga Veldhuizen

Webinar timestamps:

00:00 Welcome & GCCR updates

00:03:42 Charlotte Hautefort, senior ENT consultant  Lariboisière Hospital, Paris, France. “Mechanisms of smell loss in COVID-19: new insights from MRI studies”

00:23:35  Rick Gerkin, Associate Research Professor, co-director of The ICON Lab, Arizona State University, Tempe, USA. “Predicting COVID-19 status from chemosensory phenotype (GCCR002)”

00:43:49 Veronica Pereda-Loth & Denis Pierron, researchers in the Evolutionary Medicine team of the Laboratory of Molecular Anthropology and Image Synthesis University of Toulouse, Toulouse, France. “Self-reported smell and taste loss are early markers of the COVID-19 pandemic and of the effectiveness of political decisions (EDS001)”

00:53:30 Wrap up and discussion

01:02 Thank you and goodbye!